Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Minoxidil in breast milk may harm nursing infants.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Certain molecules in hair change with age and could be used for cosmetic treatments.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

New drugs are improving treatment for hormone-related diseases in small pets.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Leucaena leucocephala is nutritious but needs careful processing to remove toxins.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.